These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 28693290)
1. Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model. Karashima T; Udaka K; Niimura M; Suzuki K; Osakabe H; Shimamoto T; Fukata S; Inoue K; Kuroda N; Seiki M; Shuin T Oncol Lett; 2017 Jul; 14(1):1162-1166. PubMed ID: 28693290 [TBL] [Abstract][Full Text] [Related]
2. Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma. Karashima T; Komatsu T; Niimura M; Kawada C; Kamada M; Inoue K; Udaka K; Kuroda N; Shuin T Int J Urol; 2014 Jul; 21(7):702-6. PubMed ID: 24571181 [TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma. Iguchi M; Matsumoto M; Hojo K; Wada T; Matsuo Y; Arimura A; Abe K Jpn J Clin Oncol; 2009 May; 39(5):303-9. PubMed ID: 19336449 [TBL] [Abstract][Full Text] [Related]
4. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. Chang YS; Adnane J; Trail PA; Levy J; Henderson A; Xue D; Bortolon E; Ichetovkin M; Chen C; McNabola A; Wilkie D; Carter CA; Taylor IC; Lynch M; Wilhelm S Cancer Chemother Pharmacol; 2007 Apr; 59(5):561-74. PubMed ID: 17160391 [TBL] [Abstract][Full Text] [Related]
5. Targeting tumor-infiltrating Ly6G Chang CJ; Yang YH; Chiu CJ; Lu LC; Liao CC; Liang CW; Hsu CH; Cheng AL Int J Cancer; 2018 May; 142(9):1878-1889. PubMed ID: 29266245 [TBL] [Abstract][Full Text] [Related]
6. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection. Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma. Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061 [TBL] [Abstract][Full Text] [Related]
8. Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer. Wysocki PJ; Kazimierczak U; Suchorska W; Kotlarski M; Malicki J; Mackiewicz A Cancer Gene Ther; 2010 Jul; 17(7):465-75. PubMed ID: 20168352 [TBL] [Abstract][Full Text] [Related]
9. Neutralization of interleukin-2 retards the growth of mouse renal cancer. Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma. Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167 [TBL] [Abstract][Full Text] [Related]
11. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma. Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140 [TBL] [Abstract][Full Text] [Related]
12. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models. You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model. Takeuchi T; Konno-Takahashi N; Kasuya Y; Ogushi T; Nishimatsu H; Kitamura T BJU Int; 2004 Jul; 94(1):171-6. PubMed ID: 15217455 [TBL] [Abstract][Full Text] [Related]
15. Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells. Hirobe S; Yamasaki T; Ito S; Quan YS; Kamiyama F; Tachibana M; Okada N Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214117 [TBL] [Abstract][Full Text] [Related]
16. Expression of angiostatin cDNA in a murine renal cell carcinoma suppresses tumor growth in vivo. Fukumori T; Nishitani Ma; Naroda T; Onishi T; Oka N; Kanayama Ho; Kagawa S Urology; 2002 Jun; 59(6):973-7. PubMed ID: 12031397 [TBL] [Abstract][Full Text] [Related]
17. Solid nanoemulsion as antigen and immunopotentiator carrier for transcutaneous immunization. Gogoll K; Stein P; Lee KD; Arnold P; Peters T; Schild H; Radsak M; Langguth P Cell Immunol; 2016 Oct; 308():35-43. PubMed ID: 27318760 [TBL] [Abstract][Full Text] [Related]
18. Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma. Carter CA; Chen C; Brink C; Vincent P; Maxuitenko YY; Gilbert KS; Waud WR; Zhang X Cancer Chemother Pharmacol; 2007 Feb; 59(2):183-95. PubMed ID: 16724239 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration. Hara I; Nagai H; Miyake H; Yamanaka K; Hara S; Micallef MJ; Kurimoto M; Gohji K; Arakawa S; Ichihashi M; Kamidono S Cancer Gene Ther; 2000 Jan; 7(1):83-90. PubMed ID: 10678360 [TBL] [Abstract][Full Text] [Related]
20. Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma. Doehn C; Esser N; Pauels HG; Kiessig ST; Stelljes M; Grossmann A; Jocham D; Drevs J Eur Urol; 2009 Jul; 56(1):123-31. PubMed ID: 18550267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]